183793-47-7

Basic information

• Product Name: L-Serine, N-[(1,1-dimethylethoxy)carbonyl]-O-methyl-, phenylmethyl ester
• CAS NO: 183793-47-7
• Molecular Formula: C16H23NO5
• Molecular Weight: 309.362
• Mol File: 183793-47-7.mol
• Article Data: 7

Chemical Properties

• CAS DataBase Reference: L-Serine, N-[(1,1-dimethylethoxy)carbonyl]-O-methyl-, phenylmethyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: L-Serine, N-[(1,1-dimethylethoxy)carbonyl]-O-methyl-, phenylmethyl ester(183793-47-7)
• EPA Substance Registry System: L-Serine, N-[(1,1-dimethylethoxy)carbonyl]-O-methyl-, phenylmethyl ester(183793-47-7)

Safety Data

• Hazardous Substances Data: 183793-47-7(Hazardous Substances Data)

Upstream product

• 501-53-1 benzyl chloroformate 
• 51293-47-1 N-tert-butoxycarbonyl-(S)-O-methyl-serin 

Downstream Products

• 1148157-32-7 C₂HF₃O₂*C₁₅H₂₂N₂O₅ 
• 161561-84-8 N-Boc-O-methyl-L-serinamide 
• 51293-47-1 N-tert-butoxycarbonyl-(S)-O-methyl-serin 
• 1148157-33-8 benzyl (2S)-3-methoxy-2-[(2S)-3-methoxy-2-[(2-methyl-1,3-thiazol-5-yl)formamido]propanamido]propanoate 
• 935888-09-8 benzyl (2S)-2-[(2S)-2-{[tert-butoxycarbonyl]amino}-3-methoxypropanamido]-3-methoxypropanoate 
• 694527-83-8 N-((2R,3R)-3-hydroxy-2-methylnonanoyl)-N-Me-L-Leu-L-allo-Ile-L-Ser(Me)-OBn 
• 694527-71-4 (S)-2-{(2S,3R)-2-[(S)-2-(tert-Butoxycarbonyl-methyl-amino)-4-methyl-pentanoylamino]-3-methyl-pentanoylamino}-3-methoxy-propionic acid benzyl ester 
• 694527-72-5 N-Me-L-Leu-L-allo-Ile-L-Ser(Me)-OBn 
• 694527-69-0 Boc-L-allo-Ile-L-Ser(Me)-OBn 

Relevant articles and documents

IMMEDIATE RELEASE FORMULATIONS FOR OPROZOMIB

This disclosure features immediate release pharmaceutical formulations (e.g., solid dosage forms, e.g., tablets) that are useful for the oral administration of oprozomib, or a pharmaceutically acceptable salt thereof, to a human or animal subject as well as methods of making and using the formulations.

PROTEASOME INHIBITORS

The present invention relates to a compound of formula (I), wherein X is C=0, C=S or B-OH; Y is an electrophile and Z is a leaving group, or Y══Z is an electrophile; R1 comprises or consists of (a) (i) a first group binding to a proteolytic sit

CRYSTALLINE TRIPEPTIDE EPOXY KETONE PROTEASE INHIBITORS

The invention relates to crystalline tripeptide keto epoxide compounds, methods of their preparation, and related pharmaceutical compositions.